Got cash? Consider these high-flying growth stocks.
News & Analysis: Novocure
It's a good stock, but it might struggle to make you rich overnight.
Did the market overreact to the company's good news?
NVCR earnings call for the period ending March 31, 2021.
Once a stock goes up 50% in a single day, it can be hard to keep the momentum going.
The company's Tumor Treating Fields therapy looks very promising in treating lung cancer.
Novocure has provided stellar returns over the last five years, now up 17 times. Recent positive news may keep its stock going up.
The oncology specialist's investigational cancer treatment could be a game-changer.
A trial examining the use of Novocure's tumor-treating field technology in non-small cell lung cancer patients could enroll fewer patients over a shorter period, based on recommendations by an independent committee.
NVCR earnings call for the period ending December 31, 2020.